| 名稱 | FGFR3-TACC3/BaF3 |
| 型號 | CBP73297 |
| 報價 |  |
| 特點 | FGFR3-TACC3/BaF3 |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
電話：4008750250
號碼：
手機：18066071954
地址：南京市棲霞區(qū)緯地路9號
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73297FGFR3-TACC3/BaF3
- 詳細(xì)內(nèi)容
| CBP73297 | |
| I. Introduction | |
Cell Line Name： | FGFR3-TACC3/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
FGFR3-TACC3 results from the fusion of FGFR3 and TACC3, demonstrating constitutive kinase activity, transforming activity in culture and ability to drive tumor growth in xenografts (PMID: 25294908, PMID: 22837387). FGFR3-TACC3 has been identified in lung adenocarcinoma and glioblastoma (PMID: 25294908, PMID: 22837387). | |
| III. Representative Data | |
1.WB of FGFR3-TACC3/BaF3
| |
2. Sanger of FGFR3-TACC3/BaF3
| |
3. Anti-proliferation assay
Figure 3. CTG Proliferation Assay of BaF3 FGFR3-TACC3 Cells (C3). | |
